AU2011237122B2 - Easily dosable solid preparation - Google Patents

Easily dosable solid preparation Download PDF

Info

Publication number
AU2011237122B2
AU2011237122B2 AU2011237122A AU2011237122A AU2011237122B2 AU 2011237122 B2 AU2011237122 B2 AU 2011237122B2 AU 2011237122 A AU2011237122 A AU 2011237122A AU 2011237122 A AU2011237122 A AU 2011237122A AU 2011237122 B2 AU2011237122 B2 AU 2011237122B2
Authority
AU
Australia
Prior art keywords
thickener
mass
coating
sodium alginate
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011237122A
Other languages
English (en)
Other versions
AU2011237122A1 (en
Inventor
Yumio Kudou
Kuniomi Warabino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of AU2011237122A1 publication Critical patent/AU2011237122A1/en
Application granted granted Critical
Publication of AU2011237122B2 publication Critical patent/AU2011237122B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2011237122A 2010-03-31 2011-03-30 Easily dosable solid preparation Ceased AU2011237122B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010-082759 2010-03-31
JP2010082759 2010-03-31
PCT/JP2011/058133 WO2011125798A1 (ja) 2010-03-31 2011-03-30 易服用性固形製剤

Publications (2)

Publication Number Publication Date
AU2011237122A1 AU2011237122A1 (en) 2012-09-06
AU2011237122B2 true AU2011237122B2 (en) 2014-06-12

Family

ID=44762737

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011237122A Ceased AU2011237122B2 (en) 2010-03-31 2011-03-30 Easily dosable solid preparation

Country Status (12)

Country Link
US (2) US20120082723A1 (es)
EP (1) EP2561892B1 (es)
JP (2) JP5426018B2 (es)
KR (1) KR101767288B1 (es)
CN (2) CN104258408B (es)
AU (1) AU2011237122B2 (es)
BR (1) BR112012024683B1 (es)
CA (1) CA2788732C (es)
ES (1) ES2543108T3 (es)
MX (1) MX2012010648A (es)
RU (1) RU2574018C2 (es)
WO (1) WO2011125798A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5976657B2 (ja) 2011-09-30 2016-08-24 持田製薬株式会社 易服用性固形製剤
ES2694224T3 (es) * 2012-04-24 2018-12-19 Daiichi Sankyo Company, Limited Comprimido de desintegración oral y procedimiento para producir el mismo
JP6160813B2 (ja) * 2012-04-26 2017-07-12 キョーリンリメディオ株式会社 高含量レボフロキサシン錠剤
CN103040835B (zh) * 2013-01-14 2018-06-22 常州市亚邦医药研究所有限公司 一种含有枸橼酸西地那非的药用组合物及其制备方法
WO2014136857A1 (ja) * 2013-03-08 2014-09-12 ライオン株式会社 コーティング組成物、コーティング製剤及びその製造方法
JP6282939B2 (ja) * 2014-06-05 2018-02-21 株式会社ファンケル 耐酸性錠剤
JP6418806B2 (ja) * 2014-06-19 2018-11-07 カンロ株式会社 とろみを有するキャンディの製造方法
CN106794253B (zh) * 2014-09-03 2021-02-12 狮王株式会社 包衣制剂及其制造方法
AU2015369696B2 (en) * 2014-12-23 2019-01-24 International N&H Usa, Inc. Enteric film coating compositions, method of coating, and coated forms
TWI695722B (zh) * 2015-06-29 2020-06-11 日商大賽璐股份有限公司 固態製劑之外層用組成物及含有該外層用組成物之易服用性固態製劑
KR102671429B1 (ko) 2015-09-30 2024-05-30 주식회사 다이셀 복용 용이성 고형 제제용 입자 조성물 및 상기 입자 조성물을 포함하는 복용 용이성 고형 제제
US10232045B2 (en) * 2016-08-04 2019-03-19 Bpsi Holdings Llc Easy to swallow coatings and substrates coated therewith
JP6944822B2 (ja) * 2017-06-27 2021-10-06 持田製薬株式会社 易服用性カプセル
CN111936168A (zh) * 2018-04-17 2020-11-13 株式会社大赛璐 易服用性颗粒剂及其制造方法
EP3845250B1 (en) * 2018-08-30 2022-07-06 FUJIFILM Corporation Biocompatible material
JP7317940B2 (ja) 2019-03-04 2023-07-31 沢井製薬株式会社 フィルムコーティング組成物及び固形製剤
CN116193994A (zh) 2020-07-13 2023-05-30 麒麟控股株式会社 薄膜包衣片剂

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002275054A (ja) * 2001-03-19 2002-09-25 Dainippon Pharmaceut Co Ltd 易服用性固形製剤
EP1166777B1 (en) * 2000-06-30 2008-08-13 McNEIL-PPC, INC. Taste masked pharmaceutical particles
WO2009119290A1 (ja) * 2008-03-28 2009-10-01 リンテック株式会社 経口投与剤

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439194A (en) * 1981-09-08 1984-03-27 Merck & Co., Inc. Water and drug delivery system for suppository use
US5536511A (en) * 1994-05-06 1996-07-16 Wm. Wrigley Jr. Company Chewing gum pellet coated with a hard coating containing erythritol and xylitol
WO1998006385A1 (de) 1996-08-15 1998-02-19 Losan Pharma Gmbh Gut schluckbare orale arzneiform
CA2290624C (en) * 1997-06-06 2006-12-05 John W. Shell Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
JPH1160472A (ja) 1997-08-18 1999-03-02 Ota Seiyaku Kk フィルムコーティング用組成物
IN186245B (es) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
KR100790056B1 (ko) 2000-09-06 2007-12-31 미쯔비시 웰 파마 가부시키가이샤 경구용 입제제(粒製劑)
CA2440588C (en) * 2001-03-13 2010-02-09 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
AU2002255267B2 (en) 2001-04-24 2007-12-20 Lintec Corporation An orally administered agent and an orally administered agent/supporting substrate complex
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU2003224358A1 (en) * 2002-05-06 2003-11-17 Ranbaxy Laboratories Limited Monocompartment osmotic controlled drug delivery system
US7169450B2 (en) * 2002-05-15 2007-01-30 Mcneil-Ppc, Inc. Enrobed core
WO2004000918A1 (en) * 2002-06-19 2003-12-31 Showa Denko K. K. Hydrous gel and production process and use of the hydrous gel
JP2005289867A (ja) * 2004-03-31 2005-10-20 Lintec Corp 経口投与剤
EP1745775B1 (en) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
WO2007063553A1 (en) * 2005-11-29 2007-06-07 Ideal Cures Pvt. Ltd. Aqueous film coating composition containing sodium alginate and preparation thereof
ES2547226T5 (es) * 2006-08-30 2020-06-12 Jagotec Ag Formulaciones de dosificación oral de liberación controlada que comprenden un núcleo y una o más capas de barrera
WO2008077643A1 (en) * 2006-12-22 2008-07-03 Farmaprojects, S.A. Process for the preparation of an antibacterial quinolone compound
AU2007352009B2 (en) * 2007-03-30 2013-08-01 Lintec Corporation Process for producing preparation for oral administration
AU2008305243B2 (en) * 2007-09-28 2013-09-12 Lintec Corporation Medicinal preparation for oral administration
JP2011500553A (ja) * 2007-10-10 2011-01-06 ルピン・リミテッド ５−アミノサリチル酸またはその塩もしくは代謝産物の新規な結腸を標的とする調節放出性生体接着性製剤
CN101438734B (zh) * 2008-12-29 2012-12-12 贵州大学 刺梨涂膜保鲜剂制备及其低温保鲜的配套方法
AU2010228258A1 (en) * 2009-03-25 2011-09-29 Aska Pharmaceutical Co., Ltd. Solid preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1166777B1 (en) * 2000-06-30 2008-08-13 McNEIL-PPC, INC. Taste masked pharmaceutical particles
JP2002275054A (ja) * 2001-03-19 2002-09-25 Dainippon Pharmaceut Co Ltd 易服用性固形製剤
WO2009119290A1 (ja) * 2008-03-28 2009-10-01 リンテック株式会社 経口投与剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KENEDA K. et al., Journal of Pharmaceutical Science and Technology, 2002, vol. 62, sup., pp. 287 *

Also Published As

Publication number Publication date
CA2788732A1 (en) 2011-10-13
BR112012024683B1 (pt) 2019-09-24
CN102858373A (zh) 2013-01-02
CA2788732C (en) 2017-08-15
CN104258408A (zh) 2015-01-07
JP5871886B2 (ja) 2016-03-01
JPWO2011125798A1 (ja) 2013-07-08
CN102858373B (zh) 2014-11-26
MX2012010648A (es) 2012-11-09
EP2561892A4 (en) 2013-09-04
KR101767288B1 (ko) 2017-08-10
EP2561892B1 (en) 2015-05-06
BR112012024683A2 (pt) 2016-06-07
US20150079171A1 (en) 2015-03-19
RU2012146100A (ru) 2014-05-10
US20120082723A1 (en) 2012-04-05
CN104258408B (zh) 2017-10-03
JP5426018B2 (ja) 2014-02-26
EP2561892A1 (en) 2013-02-27
KR20130086128A (ko) 2013-07-31
ES2543108T3 (es) 2015-08-14
AU2011237122A1 (en) 2012-09-06
JP2014074039A (ja) 2014-04-24
WO2011125798A1 (ja) 2011-10-13
RU2574018C2 (ru) 2016-01-27

Similar Documents

Publication Publication Date Title
AU2011237122B2 (en) Easily dosable solid preparation
US9789068B2 (en) Easily dosable solid preparation
JP6294400B2 (ja) 易服用性固形製剤
CN106456611B (zh) 用于治疗恶心、呕吐或腹泻症状的恩丹西酮缓释固体制剂
JP2018065776A (ja) 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
WO2009027786A2 (en) Matrix dosage forms of varenicline
JP4549609B2 (ja) 被覆固形催眠製剤
TWI835118B (zh) 布瑞哌唑口溶膜組合物、其製備方法及用途
JP6688819B2 (ja) 易服用性固形製剤
JP5919173B2 (ja) 徐放性塩酸アンブロキソール口腔内崩壊錠
JP6150564B2 (ja) 口腔内速崩壊性錠剤

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired